Evaluation of the Efficacy of Standardized Uptake Value (SUV)-shape Scheme for Thyroid Volume Determination in Graves’ Disease: A Comparison with Ultrasonography

Document Type: Original Article

Authors

1 Nuclear medicine department of Quanzhou First Hospital Affiliated Fujian Medical University

2 Ultrasound department of Quanzhou First Hospital Affiliated Fujian Medical University

3 Endocrine department of Quanzhou First Hospital Affiliated Fujian Medical University

4 Nuclear Medicine department of Quanzhou First Hopital Affiliated Fujian Medical University

Abstract

Objective(s): In this study, we aimed to evaluate the efficacy of thyroid volume measurement using 99mTc pertechnetate single-photon emission computed tomography (SPECT) images, acquired by the standardized uptake value (SUV)-shape scheme designed by our expert team.
Methods: A total of 18 consecutive patients with Graves’ disease (GD) were subjected to both ultrasonographic and 99mTc pertechnetate SPECT examinations of thyroid within a five-day interval. The volume of thyroid lobes and isthmus was measured by ultrasonography (US) according to the ellipsoid volume equation. The total thyroid volume, determined as the sum of the volume of both lobes and isthmus, was recorded as TV-US (i.e., thyroid volume measured by US) and set as the reference. The thyroid volume was defined according to our SUV-shape scheme and was recorded as TV-SS (i.e., thyroid volume determined by the SUV-shape scheme). The data were analyzed using the Bland-Altman plot, linear regression analysis, Spearman’s rank correlation, and paired t-test, if necessary.
Results: The values of TV-SS (40.2±29.4 mL) and TV-US (43.0±34.7 mL) were not significantly different (t=0.813; P=0.43). The linear regression equation of the two values was determined as TV-US= 1.072 × TV-SS − 0.29(r=0.906; P<0.01).
Conclusion: The new scheme, i.e., SUV-shape scheme, exhibited potential for the measurement of thyroid volume in patients with GD.

Keywords

Main Subjects


1. Bartalena L. Diagnosis and management of Graves disease: a globe overview. Nat Rev Endocrinol.2013;9(12):724-34.
2. Sundaresh V, Brito JP, Wang Z, Prokop LJ, Stan MN, Murad MH, et al. Comparative effectiveness of therapies for Graves’ hyperthyroidism: a systematic review and network meta-analysis. J
Clin Endocrinol Metab. 2013;98(9):3671-7.
3. Mettler Jr FA, Guiberteau MJ. Essentials of nuclear medicine imaging. 6th ed. Philadelphia: Elsevier Health Sciences; 2012. P. 99-130.
4. Pant GS, Kumar R, Gupta AK, Sharma SK, Pandey AK. Estimation of thyroid mass in Graves’ disease by a scintigraphic method. Nucl Med Commun. 2003;24(7):743-8.
5. Van Isselt JW, de Klerk JM, van Rijk PP, van Gils AP, Polman LJ, Kamphuis C, et al. Comparison of methods for thyroid volume estimation in patients with Graves’ disease. Eur J Nucl Med Mol Imaging. 2003;30(4):525-31.
6. Freesmeyer M, Kuhnel C, Westphal JG. Time efficient 124I-PET volumetry in benign thyroid disorders by automatic isocontour procedures:mathematic adjustment using manual contoured
measurements in low-dose CT. Ann Nucl Med. 2015;29(1):8-14.
7. Freesmeyer M, Wiegand S, Schierz JH, Winkens T, Licht K. Multimodal evaluation of 2-D and 3-D ultrasound, computed tomography and magnetic resonance imaging in measurements of the thyroid volume using universally applicable cross-sectional imaging software: a phantom study. Ultrasound Med Biol. 2014;40(7):1453-62.
8. Mantao G, Bulin D, Yaming L, Yafu Y, Jiumao Z, Song C, et al. Evaluation of thyroid volume estimation methods using radionuclide imaging under different conditions. Chin J Nucl Med Mol Imaging.
2012;32(2):138-42.
9. Chen Y, Chen X, Li F, Ji-An L. Delineation gross tumor volume based on positron emission tomography images by a numerical approximation method. Ann Nucl Med. 2014;28(10):980-5.
10. Chen Y, Chen X, Li F, Ji-An L. Gross target volume delineation on PET images by a numerical approximation method phantom studies. Nucl Electron Detect Technol. 2014;34:1463-8.
11. Mowlavi AA, Fornasier MR, de Denaro M. Thyroid volume’s influence on energy deposition from (131)I calculated by Monte Carlo (MC) simulation. Radiol Oncol. 2011;45(2):143-6.
12. Rahman Z, Mirza SM, Arshed W, Mirza NM, Ahmed W. Influence of thyroid volume reduction on absorbed dose in 131I therapy studied by using Geant4 Monte Carlo simulation. Chinese Physics C. 2014; 38(5):056201.
13. Trimboli P, Ruggieri M, Fumarola A, D’Alò M, Straniero A, Maiuolo A, et al. A mathematical formula to estimate in vivo thyroid volume from two-dimensional ultrasonography. Thyroid. 2008;18(8):879-82.
14. Van Velden FH, Cheebsumon P, Yaqub M, Smit EF, Hoekstra OS, Lammertsma AA, et al. Evaluation of a cumulative SUV-volume histogram method for parameterizing heterogeneous intratumoural FDG uptake in non-small cell lung cancer PET studies. Eur J Nucl Med Mol Imaging. 2011;38(9):1636-47.
15. Seret A, Forthomme J. Comparison of different types of  commercial filtered backprokection and ordered-subset expectation maximization SPECT reconstruction software. J Nucl Med Technol. 2009;37(3):179–87.
16. Kojima A, Gotoh K, Shimamoto M, Hasegawa K, Okada S. Iodine- 131 imaging using 284 keV photons with a small animal CZT-SPECT system dedicated to low-medium-energy photon detection. Ann Nucl
Med. 2015;30(2):169-75.